Aura announces appointment of new chief executive officer
TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the "Company" or "Aura") (CSE:BUZZ) is very pleased to announce the appointment of Daniel Cohen to the role of Chief Executive Officer (CEO), effective immediately. Former CEO Chris Carl will continue to serve in his role as President and Corporate Secretary for Aura while Mr. Cohen assumes the role of CEO. Mr. Cohen has nearly 20 years of experience in the capital markets and most previously served as a partner and head of institutional equity sales at Beacon Securities. Prior to that, he held roles in institutional equity sales, investment banking and equity research at Wellington West Capital Markets, RBC Capital Markets and HSBC Securities. Mr. Cohen holds an MBA in Finance from McGill University and is a CFA Charterholder.
Mr. Cohen commented, "I am very pleased to be joining Aura and look forward to driving the development and execution of our corporate strategy going forward. In addition to the company's core clinics business, we intend to devote significant time and effort to pursuing international opportunities in Medicinal cannabis which we believe offers tremendous opportunity for value creation."
Chris Carl, President and Corporate Secretary added, "We are very pleased to have Dan on board and look forward to leveraging his expertise and track record in steering Aura forward. Given our recent listing on the CSE, we believe the company is well positioned to capitalize on the current market demand for differentiated cannabis businesses and we look forward to Dan helping us develop that further at Aura."
About Aura Health Inc.
Aura, through its wholly-owned Delaware subsidiary, Green Global Properties Inc. ("Green Global"), has acquired a 30% interest in four entities operating four medical marijuana clinics in Las Vegas, Nevada; Mesa, Arizona; Tucson, Arizona and Hollywood, Florida. Green Global has an option to increase its interest in each such clinic (other than the Nevada clinic) from 30% to 51% exercisable within 18 months of the clinic opening.
The Listing Statement describing the Corporation, Aura, the terms of the RTO Transaction and the business of the Corporation, prepared in accordance with applicable securities legislation, is available on the SEDAR website at www.sedar.com.
For further information, please contact:
Chris Carl, President and Secretary
Aura Health Inc.
(416) 312-9698
David Posner, Director and Chairman
Aura Health Inc.
(647) 985-6727
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "believes", "projects", "plans" and similar expressions. Forward looking information in this news release includes the following statements: (i) expected trading date on the CSE; (ii) management's belief that the listing on the CSE will increase pool of potential investors and bring other benefits, and (iii) management's plan to build an international network of vertical integrated businesses in the medical marijuana field.
Certain information contained in this press release constitutes forward-looking information, which is information relating to future events or the Corporation's future performance and which is inherently uncertain. All information other than statements of historical fact may be forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as "seek", "anticipate", "budget", "plan", "continue", "estimate", "expect", "forecast", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe" and similar words or phrases (including negative variations) suggesting future outcomes or statements regarding an outlook. Forward-looking information contained in this press release includes, but is not limited to, final acceptance of the RTO Transaction by CSE and listing of the Corporation's shares. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Corporation believes the expectations reflected in the forward-looking information are reasonable but no assurance can be given that these expectations will prove to be correct and readers are cautioned not to place undue reliance on forward-looking information contained in this press release. Some of the risks and other factors which could cause results to differ materially from those expressed in the forward-looking information contained in this press release include, but are not limited to: the risks that the RTO Transaction and associated transactions will not be accepted by the CSE, and other risks included in the Listing Statement available at www.sedar.com. The forward-looking information contained in this press release is made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as otherwise required by law.
News published on and distributed by:
